2026-09930
DEA-2026-0760-0001Notice
Comments
43
Last activity Jul 17, 2026
Deadline
Closed on Jul 18, 2026
Closed Jul 18, 2026
Net supportiSupport minus oppose · campaigns included
-86%
-86% excluding campaigns
Document
Details
The document's own metadata, straight from the source system.
- Title
- 2026-09930
- Posted
- May 18, 2026
- Comment period
- May 18, 2026 – Jul 18, 2026
- FR Doc
- 2026-09930
Analysis
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Include campaigns
Analyzed 35 of 43 comments
81%· analysis in progress
Stance breakdown
-86%
Net support
Support1Oppose31Other3Not yet analyzed8
Aggregates include form-letter campaigns. Excluding them, net support is -86% across organic comments.
Who commented
Breakdown by commenter type.
Individual
35
Not yet analyzed
8
Comments over time
Weekly arrivals, stacked by stance.
Posted May 18, 2026Deadline Jul 18, 2026
Jul 13
Support1Oppose31Other3
Support × commenter type
How each type splits across stance.
Support
Oppose
Other
Individual
3%
89%
9%
Issues raised
The docket's canonical issues. Select one to browse its comments.
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
Filter:
- Jul 17, 2026Anonymous AnonymousOpposeIndividualRead comment →
- Jul 16, 2026Anonymous AnonymousSupportIndividualRead comment →
- Jul 16, 2026Anonymous AnonymousOpposeIndividual
An individual is urging the DEA to deny Benuvia Operations, LLC.'s application to manufacture mescaline. The commenter argues that commercial manufacturing could increase pressure on peyote, which is culturally and spiritually significant to Native American communities and faces conservation challenges.
Read comment →